These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6173406)

  • 1. Antiactivator in plasma of patients with Behçet's disease.
    Tsushima H; Toki N
    J Dermatol; 1981 Oct; 8(5):379-83. PubMed ID: 6173406
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the blood fibrinolytic enzyme system of patients with cutaneous vasculitis.
    Toki N; Yamura T
    Br J Dermatol; 1980 Jul; 103(1):41-50. PubMed ID: 6775670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator activity levels in patients with Behçet's syndrome.
    Mishima H; Masuda K; Shimada S; Toki N; Tsushima H; Gocho M
    Arch Ophthalmol; 1985 Jul; 103(7):935-6. PubMed ID: 4040357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and properties of an antiactivator fraction from bovine serum.
    Nanninga LB; Guest MM
    Thromb Haemost; 1979 Oct; 42(3):855-63. PubMed ID: 92070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolysis and thrombosis in Behçet's disease.
    Sobel JD; Tabori S; Tatarski I
    Dermatologica; 1974; 148(2):93-7. PubMed ID: 4837654
    [No Abstract]   [Full Text] [Related]  

  • 6. A new determination method of antiactivator in human plasma.
    Toki N; Hayashi M; Takasugi S
    Hiroshima J Med Sci; 1979 Sep; 28(3):133-9. PubMed ID: 118141
    [No Abstract]   [Full Text] [Related]  

  • 7. Blocking of the fibrinolytic antiactivator by substituted benzoates.
    Nanninga L; Guest M
    Life Sci; 1974 Jun; 14(12):2507-11. PubMed ID: 4283613
    [No Abstract]   [Full Text] [Related]  

  • 8. Inter-alpha-antiplasmin: its distinction from antiactivator.
    Gallimore MJ
    Thromb Res; 1978 Apr; 12(4):687-92. PubMed ID: 149395
    [No Abstract]   [Full Text] [Related]  

  • 9. [The determination of antiactivator; especially inhibitors against the activator-induced fibrin clot lysis (author's transl)].
    Matsuda M; Yoshida N; Moroi M; Aoki N
    Rinsho Byori; 1976 Apr; 24(4):325-8. PubMed ID: 819683
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thromboelastographic method of determination of plasminogen proactivator, antiactivator, and antiplasmin activity].
    Levin GIa
    Lab Delo; 1975; (11):650-1. PubMed ID: 54484
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the fibrinolytic system in Behçet's disease?
    Asbeck F; Meyer-Boernecke D; van de Loo J
    Haemostasis; 1977; 6(5):303-9. PubMed ID: 598751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioimmunoassay (BIA) of tissue plasminogen activator (t-PA) and its specific inhibitor (t-PA/INH).
    Mahmoud M; Gaffney PJ
    Thromb Haemost; 1985 Jun; 53(3):356-9. PubMed ID: 3931284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of the antiactivator activity in human and animal blood plasma using tissue plasminogen activator].
    Andreenko GV; Shimonaeva EE
    Vopr Med Khim; 1983; 29(5):112-4. PubMed ID: 6417906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms.
    Aitchison R; Chu P; Cater DR; Harris RJ; Powell RJ
    Ann Rheum Dis; 1989 Jul; 48(7):590-3. PubMed ID: 2505697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of plasminogen activator from human plasma by chromatography on lysine-sepharose.
    Radcliffe R; Heinze T
    Arch Biochem Biophys; 1978 Jul; 189(1):185-94. PubMed ID: 101143
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous versus intraperitoneal administration of dextran in the rabbit: effects on fibrinolysis.
    Wagaman R; Ingram JM; Rao PS; Saba HI
    Am J Obstet Gynecol; 1986 Sep; 155(3):464-70. PubMed ID: 2428247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Studies on circulating plasminogen activator.
    Ogston D; Bennett B; Mackie M
    Thromb Diath Haemorrh; 1975 Nov; 34(2):609-10. PubMed ID: 812200
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin effect on the release of plasminogen activator inhibitors by human platelets.
    Woods AI; Lazzari MA
    Thromb Res; 1988 Oct; 52(2):119-25. PubMed ID: 3143164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue plasminogen activator inhibitor in human plasma: development of a functional assay system and demonstration of a correlating Mr = 50,000 antiactivator.
    Korninger C; Wagner O; Binder BR
    J Lab Clin Med; 1985 Jun; 105(6):718-24. PubMed ID: 3923146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human plasma plasminogen activator].
    Batista Diaz A
    Probl Gematol Pereliv Krovi; 1982; 27(1):40-4. PubMed ID: 6801643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.